Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 22 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)				Phase IV				HSC-MS-06-0478 OSP-24412, NCT00581425
	Post-Operative Concurrent Chemo-Radiotherapy Versus Post-Operative Radiotherapy for Cancer of the Head and Neck				Phase III				TROG 05.01 NCT00193895
	Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control				Phase III				01 NCT00663650
	A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCCs With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome				Phase II, Phase I				2007-018 NCT00500643
	An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)				Phase II, Phase I				CTL0408 NCT00652080
	Photodynamic Therapy in Treating Patients With Skin Cancer				Phase II				RPCI-DS-96-55 NCI-G97-1224, NCT00002975
	Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR				Phase II				2005-001098-82 NCT00240682
	Chemotherapy Followed By Autologous Natural Killer Cells and Aldesleukin in Treating Patients With Metastatic Melanoma or Kidney Cancer				Phase II				NCI-06-C-0169 NCI-P6950, NCT00354055
	A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma				Phase II				F060106002 NCT00369512
	To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC				Phase II				PEP005-009 NCT00432185


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute